Biocon to build $100M fermentation API plant in Visakhapatnam, India

Biocon is investing $100 million in a new fermentation-based active pharmaceutical ingredient (API) production facility in Visakhapatnam, India. The facility is scheduled to be commissioned by the end of 2021.

“Biocon is investing $100 million in a new fermentation production facility for drug substances and intermediates in Visakhapatnam.”dcatvci.org

• 1 source
• dcatvci.orgBiocon Investing $100 Million in New Fermentation-Based API Mfg Facility - DCAT Value Chain InsightsPatricia Van ArnumApr 7, 2020

Summarized from public sources; check the original articles before acting on it.